COST–EFFECTIVENESS ANALYSIS OF THE MONTELUKAST APPLICATION IN CHILDREN WITH BRONCHIAL ASTHM IN THE CONDITIONS OF THE REPUBLIC OF BELARUS HEALTH CARE SYSTEM
The aim of this study was to estimate the montelukast cost-effectiveness in children with mild and moderate persistent asthma in Belarus. Patients and methods. A one-year decision tree model of asthma for a hypothetical cohort of 100 children with asthma and a lack of basic therapy or taking either...
Saved in:
| Main Authors: | I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. A. Chmyreva, М. М. Sachek |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2012-10-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/282 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of montelukast in asthma treatment in 2025
by: Rafał Pawliczak
Published: (2025-02-01) -
BRONCHIAL OBSTRUCTION IN CHILDREN: A NEW SOLUTION TO AN OLD PROBLEM
by: O. I. Simonova, et al.
Published: (2015-04-01) -
Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 1
by: N. G. Astafieva, et al.
Published: (2024-04-01) -
Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 2
by: N. G. Astafieva, et al.
Published: (2024-05-01) -
The Impact of Montelukast Duration on the Risk of Neuropsychiatric Disorders in Children with Asthma: A Population-Based Cohort Study
by: Wei-Te Lei, et al.
Published: (2025-03-01)